SinoFresh to Engage CPA Firm Moore Stephens Lovelace, P.A.

Business Editors

ENGLEWOOD, Fla.--(BUSINESS WIRE)--March 11, 2004

SinoFresh HealthCare, Inc. (OTC BB: SFSH) developer of the first over-the-counter nasal spray, SinoFresh(TM) Nasal and Sinus Care, proven to kill germs and molds associated with chronic sinus and nasal conditions,

"Moore Stephens Lovelace, P.A. is an excellent choice for SinoFresh at this stage in the company's growth as a newly public corporation. Moore Stephens Lovelace, P.A. has significant experience in the healthcare industry and working with public clients. Also, the firm has a strong presence in Florida and the ability to offer international services in foreign markets through Moore Stephens International Limited," said Charles Fust, Chairman and CEO of SinoFresh.

Fust added, "We will be engaging Moore Stephens Lovelace, P.A as the independent auditing firm assigned to complete SinoFresh's year-end 2003 audit."

Recently, Moore Stephens Lovelace, P.A. was ranked among the country's top 50 auditors, according to Bowman's Accounting Report. The ranking is based on average sales per public client audited, total clients, and total sales audited. Moore Stephens Lovelace, P.A. is one of only two Florida firms included on the list.

Moore Stephens Lovelace, P.A. meets the national and international service needs of its clients through membership in Moore Stephens North America, Inc. and Moore Stephens International Limited, a network of independently owned and operated accounting firms around the world. Moore Stephens is regarded as one of the world's top twenty accounting and consulting networks with more than 250 member firms and offices in some 91 countries.

About SinoFresh HealthCare, Inc.

SinoFresh HealthCare, Inc. is the developer of the first over-the-counter antiseptic nasal spray proven to kill germs and reduce molds responsible for chronic sinus distress. This condition affects more than 37 million Americans every day. The company holds several patents on its innovative pharmaceutical technology, and is involved in the research and development of many forms of chronic respiratory disorders. SinoFresh relies upon a distinguished panel of medical experts and a management team experienced in the bio-pharmaceutical arena. More information is available at www.sinofresh.com.

About Moore Stephens Lovelace, P.A.

Moore Stephens Lovelace, P.A., certified public accountants and management consultants, offers complete auditing, accounting, tax and management consulting services, along with specialized healthcare, hospitality, SEC and not-for-profit services. In 2004, the firm celebrated its 30th anniversary of serving clients. With four offices and over 70 professionals, the firm ranks as one of the top independent CPA and management consulting firms in the Southeast. The offices are located in Orlando, Clearwater, Miami, and Tallahassee, Florida.

The foregoing press release contains "forward-looking statements." In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, laboratory data, collected human experience, expert opinion, traditional medical practices, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, outcomes of litigation, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in our forward-looking statements. Additional factors that could materially affect our forward-looking statements include, among other things, general economic and business conditions; the future results of planned clinical trials; changes in the understanding of science and medical pathology; the success of our brand awareness campaign; our ability to raise additional capital through the offering of equity securities; competition; our ability to build strategic relationships with major retail chain stores; required accounting changes; our relationship with AccuMed; approval of our products by the FDA for OTC sales; the protection of our intellectual property rights; ensuring the commercialization of our products does not infringe upon the intellectual property rights of others; and other factors over which the company has little or no control.

* SinoFresh(TM) is a registered trademark of SinoFresh HealthCare, Inc.